2024 mAbTalk symposium
AntibodyPlus - Bispecific Antibodies and Antibody-Drug Conjugates
Dec. 15, 2024, 2 p.m. US/PT
In person
Login to view recordings
Dec. 15, 2024, 2 p.m. US/PT
In person
Login to view recordings
“AntibodyPlus” is a novel concept coined in 2021 by the Chinese Antibody Society, and we believe this concept reflects the future trend of antibody-based therapeutics. Many antibody-based modalities, such as bispecific/multi-specific antibodies and antibody-drug conjugates (ADCs), fall within the scope of this concept. Historically, the concept of antibody-drug conjugates (ADCs) originated over a century ago, while the concept of bispecific antibodies emerged after the advent of hybridoma technology in 1975. In 2015, the development of bispecific ADCs began to gain momentum, but most projects faced significant challenges. Currently, there are about 15 BsADCs are in clinical trials globally, with three in Phase III clinical trials. To better explore the development of bispecific antibodies and antibody-drug conjugates (ADCs), the Chinese Antibody Society and its official journal, Antibody Therapeutics, will hold the 2024 mAbTalk Symposium on the first day of the 2024 Antibody Engineering & Therapeutics (AET) conference. The symposium will take place on December 15, 2024 (Sunday), with the theme "Antibody Plus: Bispecific Antibodies and Antibody-Drug Conjugates."
The symposium will feature multiple experts in antibody therapeutics, focusing on innovative technologies related to bispecific antibodies and bispecific ADCs. More guest speakers will be announced soon, so please stay tuned for updates on our official website and public account.
Registration for the 2024 mAbTalk Symposium of the Chinese Antibody Society is now open. This event is free of charge and exclusive to all members of the Chinese Antibody Society. If you are not yet a member of the Chinese Antibody Society and would like to attend this event, you are welcome to register online to become a member of our society.
Event location: Hilton San Diego Bayfront, 1 Park Boulevard, San Diego, CA 92101
Time: December 15, 2024, 2:00 PM-8:00 PM, PST (local time)
Free for CAS members
Due to limited venue capacity, this event will operate on a first-come, first-served basis. We encourage everyone to register as early as possible. Once we reach the maximum capacity, event registration will be automatically closed. If you need to withdraw your registration from the event, please notify our society through email at conference@chineseantibody.org no later than December 7, 2024.
Additionally, sponsorship opportunities for the mAbTalk Symposium are now open. If your organization/company is interested in sponsoring this symposium, please contact us via email at sponsor@chineseantibody.org.
Hover above speaker cards to read bio
Mitchell Ho
Director Board of Directors, Chinese Antibody Society
Yue Liu
CEO, Ab Studio
Stephen Demarest
CSO, Tentarix Biotherapeutics
Gerhard Frey
SVP Technology Development, BioAtla
Jianzhong Wen
Senior Principal Scientist and Manager, Merck
Starts at 12/15/2024 2 p.m. US/PT
Hover to view abstract
12/15/2024 1 p.m. US/PT
Registration
Organizer, , The Chinese Antibody Society
12/15/2024 2 p.m. US/PT
The Evolution of Antibody Therapeutics Journal
Mitchell Ho, Editor-in-Chief, Antibody therapeutics and Senior Investigator, NIH
12/15/2024 2:15 p.m. US/PT
Development of Next Generation TCEs with Computer Aided Design
Yue Liu, CEO, Ab Studio
12/15/2024 2:50 p.m. US/PT
Design of Multispecific TentaclesTM for Cell-Specific Immune Targeting in Antoimmunity and Oncology
Stephen Demarest, CSO, Tentarix Biotherapeutics
12/15/2024 3:25 p.m. US/PT
Break
Chinese Antibody Society, TBD, TBD
12/15/2024 4 p.m. US/PT
NextGen Conditionally Active ADCs
Gerhard Frey, SVP Technology Development, BioAtla
12/15/2024 4:35 p.m. US/PT
Integrating Preclinical Data by Mechanistic QSP Models to Guide ADC Design and Selection
Jianzhong Wen, Senior Principal Scientist and Manager, Merck
12/15/2024 5:10 p.m. US/PT
Break
Chinese Antibody Society, TBD, TBD
12/15/2024 5:40 p.m. US/PT
Panel Discussion
Chinese Antibody Society, TBD, TBD
12/15/2024 6:30 p.m. US/PT
Dinner
Chinese Antibody Society, TBD, TBD
